Chinese Body Pledges Action Over Quality Concerns

Follows Suggestions Of Low Efficacy From Healthcare Professionals

China’s National Healthcare Security Administration has responded to reports of complaints from Chinese healthcare professionals about the quality and efficacy of generics purchased through the country’s volume-based procurement scheme.

China will examine generic drug quality (Shutterstock)

More from Regulation

More from Products